SNGX Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

-0.270

-76.32%

-0.460

-56.6%

-0.280

-65.85%

Estimates Revision

The market is revising No Change the revenue expectations for Soligenix, Inc. (SNGX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -24.58%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-24.58%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Soligenix Inc (SNGX.O) is -1.17, compared to its 5-year average forward P/E of -1.81. For a more detailed relative valuation and DCF analysis to assess Soligenix Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.81

Current PE

-1.17

Overvalued PE

-0.26

Undervalued PE

-3.36

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

19.50

Current PS

38.19

Overvalued PS

35.97

Undervalued PS

3.04

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

SNGX News & Events

Events Timeline

No data

News

2.0

2025-12-18PRnewswire

Soligenix Publishes Positive Phase 2a Results for SGX945 in Behçet's Disease Treatment

9.0

2025-12-17Benzinga

Soligenix Expands Psoriasis Trial, Revealing Improved Results with New Gel

9.0

2025-12-17PRnewswire

Soligenix Reports Clinical Success of Optimized SGX302 Gel for Psoriasis Treatment

People Also Watch

Frequently Asked Questions

What is Soligenix Inc (SNGX) stock price today?

The current price of SNGX is 1.35 USD — it has decreased -6.25 % in the last trading day.

What is Soligenix Inc (SNGX)'s business?

Soligenix, Inc. is a late-stage biopharmaceutical company, which is focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The Company’s segments include Specialized Biotherapeutics, and Public Health Solutions. Its Specialized BioTherapeutics business segment is engaged in developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). Its Public Health Solutions segment includes development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious diseases and its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax, its vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2).

What is the price predicton of SNGX Stock?

Wall Street analysts forecast SNGX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNGX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Soligenix Inc (SNGX)'s revenue for the last quarter?

Soligenix Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

What is Soligenix Inc (SNGX)'s earnings per share (EPS) for the last quarter?

Soligenix Inc. EPS for the last quarter amounts to -0.58 USD, decreased -25.64 % YoY.

What changes have occurred in the market's expectations for Soligenix Inc (SNGX)'s fundamentals?

How many employees does Soligenix Inc (SNGX). have?

Soligenix Inc (SNGX) has 14 emplpoyees as of January 10 2026.

What is Soligenix Inc (SNGX) market cap?

Today SNGX has the market capitalization of 13.62M USD.